CRISPR in Animals and Animal Models

1 Edición, Volumen 152 - 10 de noviembre de 2017
Última edición
Editores: Raul Torres-Ruiz, Sandra Rodriguez-Perales
Idioma: Inglés

CRISPR in Animals and Animal Models, Volume 152, the latest release in the Progress in Molecular Biology and Translational Science series, explores the genome editing CRISPR s… Leer más

Descripción

CRISPR in Animals and Animal Models, Volume 152, the latest release in the Progress in Molecular Biology and Translational Science series, explores the genome editing CRISPR system in cells and animal models, its applications, the uses of the CRISPR system, and the past, present and future of CRISPR genome editing. Topics of interest in this updated volume include a section on CRISPR history, The genome editing revolution, Programming CRISPR and its applications, CRISPR Delivery methods, CRISPR libraries and screening, CRISPR investigation in haploid cells, CRISPR in the generation of transgenic animals, CRISPR therapeutics, and Promising strategies and present challenges.

Puntos claves

Accessible to students and researchers alike
Written by leading authorities in the field

De interès para

Scientists whose work is focussed on the generation of cells and animals models of different human malignancies and also those involved in gene therapy approaches.

Índice

1. CRISPR History: Discovery, Characterization, and Prosperity
Wenyuan Han and Qunxin She

2. CRISPR/Cas9 Technology: Applications and Human Disease Modeling
Marta Martinez-Lage, Raúl Torres-Ruiz and Sandra Rodriguez-Perales

3. Dynamics of Indel Profiles Induced by Various CRISPR/Cas9 Delivery Methods
Michael Kosicki, Sandeep Sundara Rajan, Flaminia C. Lorenzetti, Hans H. Wandall, Yoshiki Narimatsu, Emmanouil Metzakopian and Eric P. Bennett

4. CRISPR Libraries and Screening
John T. Poirier

5. Genome Engineering Using Haploid Embryonic Stem Cells
Takuro Horii and Izuho Hatada

6. CRISPR in Animals and Animal Models
Ellen Shrock and Marc Guell

7. Gene Editing and CRISPR Therapeutics: Strategies Taught by Cell and Gene Therapy
Juan C. Ramirez

Reseñas

Praise for the Series:
"Maintains the tradition and set-up of the previous volumes and certainly provides up-to-date data on varied aspects of cytology...a valuable acquisition to any library."—The Nucleus

Detalles del producto

Edición: 1
Última edición
Volumen: 152
Publicado: 10 de noviembre de 2017
Idioma: Inglés

Sobre los editores

Raul Torres-Ruiz

Raúl Torres-Ruiz graduated in Biological Sciences (2004) and obtained his PhD in Molecular Biology (2013) for his studies related to genome engineering and viral vectors. His research work is based on the development of Genome Engineering novel technologies. This new technologies are characterized by a high potential in the study of causes and mechanisms involved in the development of human diseases. He has implemented the CRISPR-Cas9 system to reproduce chromosomal rearrangements characteristics of human neoplasias. One of the main objectives of our group was the development of methods and tools for human cell gene editing with therapeutic purposes and to model human illnesses. During this time, I have also work in the generation of novel systems for virus delivery (AAV, Adenovirus y Lentivirus) improving their potential as tools for basic and applied experimentation. In fact, one of those systems has been translated in a patent license.

Afiliaciones y experiencia

Molecular Cytogenetics and Genome Engineering Unit, Spanish National Cancer Research Centre, Madrid, Spain

Sandra Rodriguez-Perales

Sandra Rodriguez-Perales graduated in Biological Sciences (1999) and obtained her PhD in Genetics (2004) for her studies on cancer related chromosomal translocations. After that period, she was awarded with a Postdoctoral Fellowship and joined the LMB-MRC (Cambridge, UK) during which period her interest centred on the induction of chromosomal translocations in animal models. In 2008, she joined as Scientific Researcher in the Molecular Cytogenetics Unit (CNIO, Madrid) applying genome engineering for the reproduction of chromosomal rearrangements and point mutations in human stem cells. Since 2008, she has been co-responsible for the cytogenetic diagnosis of hematologic malignancies and solid tumours and for providing extremely specialised, cutting edge technologies in molecular cytogenetics such as Spectral Karyotyping (SKY), fluorescence in situ hybridisation (FISH) for diagnosis and research, and array-based Comparative Genomic Hybridisation (aCGH) for the analysis of genomic aberrations. In 2008, she obtained the Clinical Cytogeneticist Licensure by the Spanish Association of Human Genetics (AEGH).